The National Quality Forum endorsed six new quality measures and reaffirmed its support for 10 existing quality measures related to the diagnosis and treatment of breast and colon cancers.

The new and existing measures, some of which have been endorsed for more than three years, were examined as part of a cancer endorsement maintenance project to ensure new and existing measures are harmonized, reflect current science and address gaps in existing measures, according to an Oct. 23 statement. The public is invited to request that NQF reconsider any of the 16 measures until Nov. 21.

Requests to reconsider measures can be made by submitting an appeal on the NQF measure database and the 16 recently endorsed measures are listed in a written statement from NQF.